Meitheal’s products are intended solely for use consistent with FDA-approved labelling and applicable standards of care. Moreover, Meitheal is committed to adhering to regulations that promote transparency within the pharmaceutical supply chain to protect public health. In line with this commitment, and to protect the quality and integrity of our drug products, Meitheal strongly opposes any efforts by States to subvert our distribution controls or to seek to conceal the supply chain for drugs acquired for use in capital punishment.